New Zealand markets close in 3 hours 56 minutes

MRNA Jan 2024 600.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.01000.0000 (0.00%)
As of 11:43AM EDT. Market open.
Full screen
Previous close0.0100
Expiry date2024-01-19
Day's range0.0100 - 0.0100
Contract rangeN/A
Open interest686
  • Zacks

    Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know

    In the latest trading session, Moderna (MRNA) closed at $100.27, marking a +0.83% move from the previous day.

  • Financial Times

    EU in talks with Moderna over new vaccine supply deal

    Brussels is negotiating a new Covid-19 vaccine procurement deal with US drugmaker Moderna as EU health authorities grow concerned about a rise in coronavirus infections. The deal is being negotiated between Brussels and the Boston-based biotechnology group, two people familiar with the matter said, with member states able to confirm their interest on an individual basis. At least eight EU countries were interested in opting into a new supply deal, one of the people said, adding that the contract was specifically for messenger ribonucleic acid-based Covid-19 vaccines.

  • Yahoo Finance Video

    New COVID vaccine rollout running into insurance, supply roadblocks

    The rollout of new COVID-19 vaccines is being obstructed by insurance and supply roadblocks, as customers experience issues with getting insurers to agree on vaccine coverage. The Department of Health and Human Services wrote a letter to insurers stating, "Your obligation as a plan or issuer to ensure that your members have coverage for COVID-19 vaccines without cost sharing is not conditional upon parties' compliance." Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down the news. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.